Leafy Tunnel Overview

Leafy Tunnel is an early-stage venture capital firm based in London, UK, focusing on investments in alternative medicine, particularly medicinal cannabis and psychedelics, to address mental health and pain disorders. The firm aims to support pioneering companies leading research, development, and commercialization in these sectors. In January 2022, Leafy Tunnel announced the first closing of its Guernsey-based fund, targeting a total of $30 million, with plans to invest in up to 15 companies. As of that date, the firm had already made seven investments, including Beckley Psytech, Tetra Pharm Technologies, Iuvo Therapeutics, Maya Health, Prohibition Holdings, Tactogen, and Ceretype. Leafy Tunnel's investment strategy focuses on European medical cannabis and global medical psychedelics companies at Seed and Series A stages. The firm is an appointed representative of Midmar Capital LLP, which is authorized and regulated by the Financial Conduct Authority in respect of UK investment advisory or arranging activities.

Is Leafy Tunnel the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Leafy Tunnel, along with a list of other relevant VCs, is available on Hopohopo.io.